Dr. Soltesz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
- Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery, 2005 - 2007
- Brigham and Women's HospitalResidency, Surgery, 1998 - 2005
- Harvard Medical SchoolClass of 1998
Certifications & Licensure
- OH State Medical License 2006 - 2026
- PA State Medical License 2009 - 2016
- MA State Medical License 2001 - 2010
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation Start of enrollment: 2009 Mar 01
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Contact, Principal Investigator, Sub-Investigator
Publications & Presentations
PubMed
- 71 citationsOptimal Strategy and Timing of Left Ventricular Venting During Veno-Arterial Extracorporeal Life Support for Adults in Cardiogenic Shock: A Systematic Review and Meta-...Abdulrahman A. Al-Fares, Varinder K. Randhawa, Marina Englesakis, Michael McDonald, A. Dave Nagpal
Circulation. Heart Failure. 2019-11-01 - 311 citationsEx-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trialAbbas Ardehali, Fardad Esmailian, Mario C. Deng, Edward G. Soltesz, Eileen Hsich
Lancet. 2015-06-27 - 37 citationsThe new heart transplant allocation system: Early observations and mechanical circulatory support considerations.Jerry D. Estep, Edward G. Soltesz, Rebecca Cogswell
The Journal of Thoracic and Cardiovascular Surgery. 2021-05-01
Press Mentions
- Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist HerzpumpeFebruary 1st, 2021
- Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssistJanuary 29th, 2021
- Atrial Arrhythmias in LVAD Recipients Don’t Compromise Outcomes in Large Cohort StudyApril 26th, 2019
- Join now to see all
Grant Support
- Gene Therapy For Chronic Heart FailureNational Heart, Lung, And Blood Institute2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: